Cohance Lifesciences

quarterly
yearly
ParticularsSep '24Dec '24Mar '25Jun '25Sep '25
Revenue619.96322.86852.47563.48571.17
Expenses445.80213.13675.82492.62487.40
EBITDA221.56133.41241.27126.18136.55
EBIT183.77113.06171.3272.9492.53
Profit Before Tax174.16109.73160.8762.7683.77
Net Profit138.2483.29117.1546.4066.39
Financial Ratios
Operating Profit Margin36.70%43.43%26.83%21.50%24.58%
Net Profit Margin22.93%26.98%15.70%9.95%13.33%
Earning Per Share (Diluted)3.613.233.101.271.93
Dividends Per Share0.000.000.000.000.00